Literature DB >> 21387101

Rating the quality of evidence and the strength of recommendations using GRADE.

Steven E Canfield1, Philipp Dahm.   

Abstract

OBJECTIVES: Urologists can benefit from a standardized system for guideline development and presentation. This article introduces the GRADE system and explains how it may be useful for Urologic physicians, in their practice and in their healthcare systems.
METHODS: The GRADE system is reviewed. Specific aspects of how GRADE rates the quality of the evidence and the strength of recommendations are explored.
RESULTS: GRADE can provide explicit and structured guidance, which separates the quality of evidence from the strength of recommendations. This information can be used by consumers of guidelines, including patients, physicians, and policy makers.
CONCLUSIONS: Urologists can benefit from a more transparent and rigorous framework when formulating recommendations. GRADE is an emergent proposal with broader implications for healthcare policy as well.

Entities:  

Mesh:

Year:  2011        PMID: 21387101     DOI: 10.1007/s00345-011-0667-2

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  19 in total

Review 1.  Medical therapy to facilitate the passage of stones: what is the evidence?

Authors:  Christian Seitz; Evangelos Liatsikos; Francesco Porpiglia; Hans-Göran Tiselius; Ulrike Zwergel
Journal:  Eur Urol       Date:  2009-06-21       Impact factor: 20.096

Review 2.  Incorporating considerations of resources use into grading recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; Roman Jaeschke; Mark Helfand; Alessandro Liberati; Gunn E Vist; Holger J Schünemann
Journal:  BMJ       Date:  2008-05-24

3.  Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.

Authors:  Holger J Schünemann; A Holger J Schünemann; Andrew D Oxman; Jan Brozek; Paul Glasziou; Roman Jaeschke; Gunn E Vist; John W Williams; Regina Kunz; Jonathan Craig; Victor M Montori; Patrick Bossuyt; Gordon H Guyatt
Journal:  BMJ       Date:  2008-05-17

4.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

5.  Evidence-based urology in practice: incorporating patient values in evidence-based clinical decision making.

Authors:  Steven E Canfield; Philipp Dahm
Journal:  BJU Int       Date:  2009-10-10       Impact factor: 5.588

6.  Guidelines for reading literature reviews.

Authors:  A D Oxman; G H Guyatt
Journal:  CMAJ       Date:  1988-04-15       Impact factor: 8.262

7.  EAU guidelines on urinary incontinence.

Authors:  Joachim W Thüroff; Paul Abrams; Karl-Erik Andersson; Walter Artibani; Christopher R Chapple; Marcus J Drake; Christian Hampel; Andreas Neisius; Annette Schröder; Andrea Tubaro
Journal:  Eur Urol       Date:  2010-11-24       Impact factor: 20.096

Review 8.  Cost savings at the end of life. What do the data show?

Authors:  E J Emanuel
Journal:  JAMA       Date:  1996-06-26       Impact factor: 56.272

Review 9.  Medical treatment of advanced testicular cancer.

Authors:  Darren R Feldman; George J Bosl; Joel Sheinfeld; Robert J Motzer
Journal:  JAMA       Date:  2008-02-13       Impact factor: 56.272

Review 10.  Conservative management for postprostatectomy urinary incontinence.

Authors:  K F Hunter; C M A Glazener; K N Moore
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18
View more
  8 in total

1.  Imaging versus no imaging for low back pain: a systematic review, measuring costs, healthcare utilization and absence from work.

Authors:  G P G Lemmers; W van Lankveld; G P Westert; P J van der Wees; J B Staal
Journal:  Eur Spine J       Date:  2019-02-22       Impact factor: 3.134

2.  Advancing Canadian Urological Association guidelines using GRADE.

Authors:  Philipp Dahm; Jane Lewis; Shahnaz Sultan
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

Review 3.  Guidelines in cardiac clinical practice: evaluation of their methodological quality using the AGREE II instrument.

Authors:  Sanjeeve Sabharwal; Vanash Patel; Sukhjinder S Nijjer; Ali Kirresh; Ara Darzi; John C Chambers; Iqbal Malik; Jaspal S Kooner; Thanos Athanasiou
Journal:  J R Soc Med       Date:  2013-05-28       Impact factor: 5.344

4.  Influenza vaccines licensed in the United States in healthy children: a systematic review and network meta-analysis (Protocol).

Authors:  Gabriela J Prutsky; Juan Pablo Domecq; Tarig Elraiyah; Zhen Wang; Lisa A Grohskopf; Larry J Prokop; Victor M Montori; Mohammad Hassan Murad
Journal:  Syst Rev       Date:  2012-12-29

5.  Is self-monitoring of blood glucose effective in improving glycaemic control in type 2 diabetes without insulin treatment: a meta-analysis of randomised controlled trials.

Authors:  Hongmei Zhu; Yanan Zhu; Siu-Wai Leung
Journal:  BMJ Open       Date:  2016-09-02       Impact factor: 2.692

Review 6.  Relationship between Subclinical Thyroid Dysfunction and the Risk of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Cohort Studies.

Authors:  Jing Sun; Liang Yao; Yuan Fang; Ruifei Yang; Yaolong Chen; Kehu Yang; Limin Tian
Journal:  Int J Endocrinol       Date:  2017-08-31       Impact factor: 3.257

7.  Patient- and proxy-reported outcome measures instruments for the assessment of asthma control among adult and pediatric population: A protocol for systematic review.

Authors:  Thayla A Santino; Karolinne Souza Monteiro; Matheus de Paiva Azevedo; Cecília M Patino; Sara Ahmed; Karla M P P de Mendonça
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

Review 8.  Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia.

Authors:  Philipp Dahm; Roderick MacDonald; Lauren McKenzie; Jae Hung Jung; Nancy Greer; Timothy Wilt
Journal:  Eur Urol Open Sci       Date:  2021-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.